{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:24:36Z","timestamp":1761863076231},"reference-count":85,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.bbagrm.2012.02.023","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T22:47:12Z","timestamp":1331074032000},"page":"1067-1074","source":"Crossref","is-referenced-by-count":21,"title":["Mitochondrial translational inhibitors in the pharmacopeia"],"prefix":"10.1016","volume":"1819","author":[{"given":"Bruce H.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell P.","family":"Saneto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagrm.2012.02.023_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ddrr.106","article-title":"Pharmacologic effects on mitochondrial function","volume":"16","author":"Cohen","year":"2010","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.biochem.76.081205.150955","article-title":"Why do we have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine","volume":"76","author":"Wallace","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1515\/BC.2001.187","article-title":"An overview of endosymbiotic models for the origins of eukaryotes, their ATP-producing organelles (mitochondria and hydrogenosomes), and their heterotrophic lifestyle","volume":"382","author":"Martin","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ddrr.104","article-title":"C. molecular genetics of mitochondrial disorders","volume":"16","author":"Wong","year":"2010","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0025","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1073\/pnas.85.17.6465","article-title":"Normal oxidative damage to nuclear DNA is extensive","volume":"85","author":"Richter","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ddrr.102","article-title":"Historical perspective of mitochondrial medicine","volume":"16","author":"DiMauro","year":"2010","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ddrr.113","article-title":"Bioenergetics and the epigenome: interface between the environment and genes in common diseases","volume":"16","author":"Wallace","year":"2010","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0040","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1210333","article-title":"Degradation of paternal michondria by fertilization-triggered autophagy in C. elegans embryos","volume":"334","author":"Sato","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0045","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1126\/science.1211878","article-title":"Postfertilization autophagy of sperm organelles prevents paternal mitochondrial DNA transmission","volume":"334","author":"Al Rawi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0050","first-page":"389","article-title":"Mitochondria in innate immune responses","volume":"11","author":"West","year":"2011","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0055","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.mito.2010.02.005","article-title":"The role of mitochondria in the mammalian antiviral defense system","volume":"10","author":"Scott","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ddrr.110","article-title":"The neurological effects of mitochondrial disease","volume":"16","author":"Parikh","year":"2010","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2007.11.018","article-title":"The in-depth evaluation of suspected mitochondrial disease","volume":"94","author":"Haas","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0075","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/jnnp.14.3.216","article-title":"Subacute necrotizing encephalomyelopathy in an infant","volume":"14","author":"Leigh","year":"1951","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/archopht.1958.00940080296016","article-title":"Retinitis pigmentosa, external ophthalmoplegia, and complete heart block: unusual syndrome with histologic study in one of two cases","volume":"60","author":"Kearns","year":"1958","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0085","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI104637","article-title":"A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study","volume":"41","author":"Luft","year":"1962","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0090","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/331717a0","article-title":"Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies","volume":"331","author":"Holt","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0095","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbabio.2009.09.005","article-title":"Mitochondrial DNA mutations and human disease","volume":"1797","author":"Tuppen","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11940-009-0046-0","article-title":"A modern approach to the treatment of mitochondrial diseases","volume":"11","author":"Parkih","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0793-289","article-title":"Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness","volume":"4","author":"Prezant","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0120","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0092-8674(90)90059-N","article-title":"Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation","volume":"61","author":"Shoffner","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0125","series-title":"Drug-Induced Mitochondrial Dysfunction","first-page":"311","article-title":"Drug effects with mitochondrial diseases","author":"Schon","year":"2008"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/15216540310001626610","article-title":"Properties of human mitochondrial ribosomes","volume":"55","author":"O'Brien","year":"2003","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0135","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/j.1365-2958.2006.05063.x","article-title":"Antibiotics and the ribosome","volume":"59","author":"Tenson","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0140","first-page":"487","article-title":"Regulation of the protein synthesis machinery","volume":"Vol 1","author":"Maaloe","year":"1979"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0145","series-title":"Mitochondrial Genomics","first-page":"173","article-title":"Animal mitochondrial DNA: structure and evolution","author":"Wolstenholme","year":"1992"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.gene.2005.03.026","article-title":"Nuclear MRP genes and mitochondrial disease","volume":"354","author":"O'Brien","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0155","doi-asserted-by":"crossref","first-page":"737385","DOI":"10.1155\/2010\/737385","article-title":"Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies","volume":"2010","author":"Smits","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2217\/17460913.2.6.571","article-title":"Back to the future: the ribosome as an antibiotic target","author":"Franceschi","year":"2007","journal-title":"Future Microbiol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0165","first-page":"1811","article-title":"Aminoglycosides: a practical review","volume":"58","author":"Gonzalez","year":"1998","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0170","doi-asserted-by":"crossref","unstructured":"Henley CM, Schacht J, Pharmacokinetic of aminoglycoside antibiotics in blood, inner-ear fluids and tissues and their relationship to ototoxicity, Audiology. 27 (1088) 137\u2013146.","DOI":"10.3109\/00206098809081584"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0175","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","article-title":"Pathogenic mitochondrial DNA mutations are common in the general population","volume":"83","author":"Elliott","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0180","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ijporl.2011.01.013","article-title":"Prevalence of A1555G mitochondrial mutation in Chinese newborns and the correlation with neonatal hearing screening","volume":"75","author":"Chen","year":"2011","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0185","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1056\/NEJMc0806397","article-title":"Prevalence of mitochondrial 1555A\u2013>G mutation in adults of European descent","volume":"360","author":"Vandebona","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0190","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMc0806396","article-title":"Prevalence of mitochondrial 1555A\u2013>G mutation in European children","volume":"360","author":"Bitner-Glindzicz","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0195","first-page":"414","article-title":"Clinical significance of large-scale screening of A1555G mutation of mitochondria DNA for neonates","volume":"28","author":"Cai","year":"2011","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0200","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00125817-200209000-00004","article-title":"Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?","volume":"4","author":"Tang","year":"2002","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/00016489950181927","article-title":"Sensorineural hearing loss and the 1555G mitochondrial DNA mutation","volume":"119","author":"Hutchin","year":"1999","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbrc.2010.03.149","article-title":"Mutation analysis of mitochondrial 12S rRNA gene in Polish patients with non-syndromic and aminoglycoside-induced hearing loss","volume":"395","author":"Rydzanicz","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0196-0709(97)90078-8","article-title":"Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity","volume":"18","author":"Fischel-Ghodsian","year":"1997","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.mito.2006.11.019","article-title":"Screening of common mitochondrial mutations in Chinese patients with mitochondrial encephalomyopathies","volume":"7","author":"Qi","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0225","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.bbrc.2006.01.049","article-title":"Mitochondrial 12S rRNA gene mutations affect RNA secondary structure and lead to variable penetrance in hearing impairment","volume":"341","author":"Ballana","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/381133","article-title":"Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family","volume":"74","author":"Zhao","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0235","first-page":"165","article-title":"Modifier factors influencing the phenotypic manifestation of the deafness associated mitochondrial DNA mutations","volume":"28","author":"Yang","year":"2011","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/506389","article-title":"Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations","volume":"79","author":"Guan","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0245","doi-asserted-by":"crossref","first-page":"401e7","DOI":"10.1016\/j.ajhg.2009.08.004","article-title":"Acute infantile liver failure due to mutations in the TRMU gene","volume":"85","author":"Zeharia","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2004.01.020","article-title":"Human mitochondrial transcription factor B1 as a modifier gene for hearing loss associated with the mitochondrial A1555G mutation","volume":"82","author":"Bykhovskaya","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0255","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/hmg\/ddp208","article-title":"Elucidation of separate, but collaborative functions of the rRNA methyltransferase-related human mitochondrial transcription factors B1 and B2 in mitochondrial biogenesis reveals new insight into maternally inherited deafness","volume":"15","author":"Cotney","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0260","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/367622","article-title":"Tetracycline therapy: update","volume":"15","author":"Roberts","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0265","article-title":"Minocycline exerts uncoupling and inhibiting effects on mitochondrial respiration through adenine nucleotide translocase inhibition","author":"Cuenca-Lopez","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0270","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.2741\/2031","article-title":"Mechanisms of doxycycline-induced cytotoxicity on human bronchial epithelial cells","volume":"11","author":"Sourdeval","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0275","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, application, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0280","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/0006-2952(81)90403-2","article-title":"Tissue distribution and effects on mitochondrial protein synthesis of tetracyclines after prolonged continuous intravenous administration to rats","volume":"30","author":"van den Bogert","year":"1981","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1022649516930","article-title":"The secondary structure of mammalian mitochondrial 16S rRNA molecules: refinements based upon a comparative phylogenetic approach","volume":"9","author":"Burk","year":"2001","journal-title":"J. Mammal. Evol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0290","first-page":"371","article-title":"Is chloramphenicol making a comeback?","volume":"12","author":"Nitzan","year":"2010","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0295","first-page":"44N","article-title":"Chloramphenicol toxicity: 25years of research","volume":"87","author":"Yunis","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0300","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1001\/jama.1969.03160110017004","article-title":"Statewide study of chloramphenicol therapy and fatal aplastic anemia","volume":"208","author":"Wallerstein","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0305","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00007611-198609000-00022","article-title":"Chloramphenicol: what we have learned in the last decade","volume":"79","author":"Feder","year":"1986","journal-title":"South Med. J."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM196907032810102","article-title":"Concordance for drug-induced aplastic anemia in identical twins","volume":"281","author":"Nagao","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0315","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4161\/auto.4239","article-title":"Mitochondrial DNA deletions and chloramphenicol treatment stimulate the autophagic transcript ATG12","volume":"3","author":"Prigione","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0320","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00003088-199936060-00005","article-title":"Glucuronidation in humans. Pharmacogenetic and developmental aspects","volume":"36","author":"de Wildt","year":"1999","journal-title":"Clin. Phamacokinet."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0325","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01411-05","article-title":"Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones","volume":"50","author":"McKee","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0330","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","article-title":"The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome","volume":"330","author":"Tenson","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mito.2004.05.002","article-title":"Erythromycin as a potential precipitating agent in the onset of Leber's hereditary optic neuropathy","volume":"4","author":"Luca","year":"2004","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0340","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2007.04.005","article-title":"The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria","volume":"26","author":"Leach","year":"2007","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0345","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1345\/aph.1C361","article-title":"Mechanisms for linezolid-induced anemia and thrombocytopenia","volume":"37","author":"Bernstein","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0350","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/MPH.0b013e3181b1ed42","article-title":"Pure red cell precursor toxicity by linezolid in a pediatric case","volume":"31","author":"Taketani","year":"2009","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0355","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM200301023480123","article-title":"Linezolid-induced lactic acidosis","volume":"348","author":"Apodaca","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0360","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.diagmicrobio.2008.08.009","article-title":"IDSA emerging infections network. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey","volume":"62","author":"Beekmann","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0365","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/379012","article-title":"Linezolid-associated toxic optic neuropathy: a report of 2 cases","volume":"37","author":"Lee","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0370","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1592\/phco.27.8.1189","article-title":"Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome","volume":"27","author":"Narita","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0375","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/B712690P","article-title":"Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic Diseases","volume":"6","author":"Hainrichson","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0380","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0076-6879(10)78021-6","article-title":"Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases","volume":"478","author":"Pokrovskaya","year":"2010","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0385","first-page":"750","article-title":"The use of ribosomal crystal structures in antibiotic drug design","volume":"10","author":"Wimberly","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0390","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1128\/AAC.49.9.3896-3902.2005","article-title":"Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis","volume":"49","author":"Nagiec","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0395","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0400","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1128\/AAC.00663-10","article-title":"Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations","volume":"54","author":"Locke","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0405","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0076-6879(96)64020-8","article-title":"In vivo labeling and analysis of human mitochondrial translation products","volume":"264","author":"Chomyn","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0410","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09546630510011810","article-title":"Tigecycline: a review of a new glycylcycline antibiotic","volume":"16","author":"Scheinfeld","year":"2005","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0415","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"Skrti\u0107","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0420","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ccr.2011.10.028","article-title":"Power cut: inhibiting mitochondrial translation to target leukemia","volume":"20","author":"J\u00e4r\u00e5s","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagrm.2012.02.023_bb0425","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/01.wnl.0000182814.55361.70","volume":"8","author":"Nguyen","year":"2005","journal-title":"Neurology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874939912000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874939912000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T13:21:16Z","timestamp":1543152076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874939912000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":85,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1874939912000752"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagrm.2012.02.023","relation":{},"ISSN":["1874-9399"],"issn-type":[{"value":"1874-9399","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}